Skip to main content
. 2017 Nov 9;135(11):1232–1241. doi: 10.1001/jamaophthalmol.2017.4152

Figure 2. Estimated Yearly Progression of Areas Based on Lesion Size at the First Included Visit.

Figure 2.

A, Estimated growth rate in eyes with definitely decreased autofluorescence (DDAF) lesion sizes ≤1.92 mm2 (66th percentile) was 0.32 mm2/y (95% CI, 0.24-0.39 mm2/y) (brown line). B, Estimated growth rate in eyes with DDAF lesion sizes >1.92 mm2 was estimated as 0.86 mm2/y (95% CI, 0.67-1.06 mm2/y) (orange line). C, For total area of decreased areas of autofluorescence, eyes with lesion sizes ≤2.50 mm2 (66th percentile) showed an estimated growth rate of 0.26 mm2/y (95% CI, 0.21-0.32 mm2/y) (brown line). D, For total area of decreased areas of autofluorescence, eyes with lesions sizes >2.50 mm2 showed an estimated growth rate of 0.74 mm2/y (95% CI, 0.57-0.91 mm2/y) (orange line). Diagonal lines in parts A-D indicate estimated growth rates.